Staff Reporter :
IN A monumental achievement
for Indian medical research, a
team of surgeons from Netaji
Subhash Chandra Bose Medical
College (NSCBMC), Jabalpur, has
pioneered an ultra-affordable
technique for breast cancer surgery. The groundbreaking
research has been selected for
presentation at the World Cancer
Congress 2026 in Hong Kong, the
world’s largest and most prestigious cancer conference.
Resident doctor Dr Daphne
will present this game-changing research on behalf of the
Jabalpur team at the global conference in Hong Kong, bringing
international attention to India’s
capacity for low-cost, highimpact medical innovation.
In developed nations across
North America and Europe, surgeons performing breast cancer
operations rely on Targeted
Axillary Dissection (TAD).
Rather than removing all the
lymph nodes under the armpit,
TAD allows surgeons to identify and remove only the specific cancerous nodes. It prevents
severe post-surgical complications, such as lifelong arm
swelling (lymphedema) and loss
of limb function.
Dr Sanjay Kumar Yadav, Breat
Cancer Expert, NSCBMCH, stated that surprisingly, due to a lack
of awareness and prohibitively
expensive technology, over 90%
of Indian patients are still forced
to undergo traditional, more
invasive surgeries that carry high
risk of long-term disability.
While TAD technology costs
over Rs 100,000 abroad and
upwards of Rs 50,000 in top
private hospitals across India,
the research team at NSCB
Medical College has successfully developed a modified
technique that slashes the cost
to less than Rs 1,000.
Even better, patients undergoing treatment at NSCB
Medical College, Jabalpur,
receive this life-changing procedure completely free of cost.
The research team credited the
Dean, Dr Navneet Saxena,
Medical Superintendent, Dr
Arvind Sharma the administrative leadership and the Head of
the Surgery Department for their
constant guidance and unwavering support in bringing this
project to fruition. This revolutionary breakthrough not only
places Jabalpur on the global
medical map but also ensures
that advanced, tissue-sparing
breast cancer surgery becomes
accessible to every Indian, regardless of their financial background.